ADVANCE WITH IRON
Natural health product licensed in Canada
- Licence holder
- Future Formulations Inc.
- NPN or DIN-HM
- 02238600
- Status
- Active licence
- Licence date
- 19 October 2009
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- DIN de transition
If this product were sold in France
- Dose déclarée au-delà d'une limite
Magnésium: up to 400.2 mg a day according to the dosing instructions published by Health Canada (6 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 300 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Fer: up to 15 mg a day according to the dosing instructions published by Health Canada (6 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 14 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Sélénium: up to 100.2 µg a day according to the dosing instructions published by Health Canada (6 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 50 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Zinc: up to 19.98 mg a day according to the dosing instructions published by Health Canada (6 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 15 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Manganèse: up to 10.02 mg a day according to the dosing instructions published by Health Canada (6 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 3.5 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Chrome: up to 150 µg a day according to the dosing instructions published by Health Canada (6 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 25 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Magnésium: up to 400.2 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (250 mg a day). Pour ce nutriment, le repère de l'EFSA ne porte que sur les apports ajoutés (compléments, aliments enrichis), pas sur ce qu'apporte l'alimentation courante.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
- À vérifier
Manganèse: up to 10.02 mg a day according to the dosing instructions published by Health Canada, above the niveau de sécurité from EFSA for adults (8 mg a day). Son dépassement ne permet pas, à lui seul, de caractériser un risque : l'EFSA n'a pas pu fixer de limite supérieure pour ce nutriment. Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
niveau de sécurité. EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Magnésium Source : Citrate de magnésium | 66.7 mg | 400,200 µg |
| Vitamine A Source : Palmitate de vitamine A Potency : 833.3 UI | 250.25 mcg EAR | Not calculated |
| Riboflavine Source : Riboflavine | 5.86 mg | 35,160 µg |
| Riboflavine Source : Riboflavine-5-phosphate | 5.86 mg | 35,160 µg |
| Folate Source : Acide folique | 0.07 mg | Not calculated |
| Fer Source : Citrate de fer (II) | 2.5 mg | 15,000 µg |
| Sélénium Source : Produit de chélation de sélénium et de protéine végétale hydrolysée (PVH) | 16.7 mcg | 100.2 µg |
| Vanadium Source : Produit de chélation de vanadium et de PVH | 8.33 mcg | Not calculated |
| Potassium Source : Citrate de potassium | 8.33 mg | 49,980 µg |
| Biotine Source : Biotine | 50 mcg | 300 µg |
| Zinc Source : Citrate de zinc | 3.33 mg | 19,980 µg |
| Manganèse Source : Citrate de manganèse | 1.67 mg | 10,020 µg |
| Molybdène Source : Produit de chélation de molybdène et de protéine végétale hydrolysée (PVH) | 8.33 mcg | 49.98 µg |
| Thiamine Source : Chlorhydrate de thiamine | 8.33 mg | 49,980 µg |
| Chrome Source : Produit de chélation chromique et de protéine végétale hydrolysée (PVH) | 25 mcg | 150 µg |
| Vitamine D3 Source : Cholécalciférol Potency : 16.7 UI | 0.42 mcg | 2.52 µg |
| Choline Source : Dihydrogénocitrate de choline | 8.33 mg | Not calculated |
| Calcium Source : Citrate de calcium | 66.7 mg | 400,200 µg |
Non-medicinal ingredients
Maltase, Glutathione, Rutine, Protéase, Rice bran, Stéarate de magnésium, Gélatine, Bioflavonoïdes, Cellulase, Lactobacilli, Invertase
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1 Capsule ; maximum: 2 Capsule | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Daily multi vitamin mineral supplement - a factor in the maintenance of good health. Helps the body to metabolize carbohydrates, fats, and proteins. Helps in tissue formation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 02238600
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.